✦ LIBER ✦

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin

✍ Scribed by Tarik Asselah; Emilie Estrabaud; Ivan Bieche; Martine Lapalus; Simon De Muynck; Michel Vidaud; David Saadoun; Vassili Soumelis; Patrick Marcellin

Book ID: 111239326
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 521 KB
Volume: 30
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2010.02283.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment with pegylated interferon pl

Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis

✍ Calogero Cammà; Giuseppe Cabibbo; Fabrizio Bronte; Marco Enea; Anna Licata; Mass 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Association of Interleukin-28B and Hepat

Association of Interleukin-28B and Hepatitis C Genotype 1 with a High Viral Load and Response to Pegylated Interferon plus Ribavirin Therapy

✍ Takita, Masahiro; Hagiwara, Satoru; Arizumi, Tadaaki; Hayaishi, Sousuke; Ueda, T 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 360 KB

Are viral or host factors predictive of

Are viral or host factors predictive of response to interferon–ribavirin in transplant patients with hepatitis C?

✍ Bruno Roche; Didier Samuel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 225 KB

[640] BASELINE FACTORS ASSOCIATED WITH A

[640] BASELINE FACTORS ASSOCIATED WITH ANEMIA DURING PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C

✍ J.P. Sampaio; P.N. El Batah; L.L. Schiavon; R.J. Carvalho Filho; J.L. Narciso; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Factors associated with efficacy of pegy

Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation

✍ Li, Ling-Fei; Shi, Ke-Qing; Lin, Yi-Qian; Wang, Li-Ren; He, Jiang-Ping; Braddock 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Association of host pharmacodynamic effe

Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C

✍ Raymond T. Chung; Fred F. Poordad; Tarek Hassanein; Xiaolei Zhou; Ellen Lentz; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Patients receiving therapy for chronic hepatitis C virus (HCV) infection frequently experience cytopenias and weight loss. We retrospectively assessed the pharmacodynamic effects of pegylated interferon (PEG-IFN) alfa-2a and ribavirin by evaluating the relationship between changes in hematologic par